Inhaled corticosteroid overuse and deprescribing eligibility in COPD (iCODEC Study): a nationwide cross-sectional analysis in China.

NPJ Prim Care Respir Med · 2026 · PMC13332176 · PMID 42049788

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

Under the ERS criteria, hospital tier was not a statistically significant predictor of eligibility for ICS deprescribing; nevertheless, a clear trend toward higher eligibility in secondary hospitals than in tertiary hospitals was observed (aOR 1.07; 95% CI: 0.98-1.18).

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.